Literature DB >> 22593993

Intracerebral metastasis of glioblastoma multiforme. Case report and literature review.

Dariusz Jezewski1, Dominika Parafiniuk, Przemysław Nowacki, Ireneusz Kojder.   

Abstract

Glioblastoma multiforme is the most common primary malignant brain tumor in adults. It's characterized by a high malignancy and rapid, frequent tendency to local recurrence. Distant metastases disseminated in the brain compared to the primary lesion and outside the central nervous system are rarely reported in the literature. The case which is being presented is of a 53 year old man operated in 2008 because of Glioblastoma multiforme IV WHO in the left periventricular parietal region, in which the main symptoms were the Gerstmann syndrome, mixed aphasia and memory disturbance. The patient was operated totally followed by adjuvant radiotherapy and chemotherapy. Two years later epileptic seizures and aphasia were intensified. Due to this adverse symptoms MRI was ordered, which revealed a tumor in the left periventricular temporal region in different location compared to the primary lesion. The patient was operated by temporal lobectomy. Histopathological diagnosis was Glioblastoma multiforme IV WHO. According to the literature we analyzed the natural GBM tumor features and factors responsible for possibility to appear of the same type of tumor in another location of the brain.

Entities:  

Mesh:

Year:  2011        PMID: 22593993

Source DB:  PubMed          Journal:  Ann Acad Med Stetin        ISSN: 1427-440X


  2 in total

1.  Interplay between PCBP2 and miRNA modulates ARHGDIA expression and function in glioma migration and invasion.

Authors:  Xihua Lin; Bin Yang; Wei Liu; Xiaochao Tan; Fan Wu; Peishan Hu; Tao Jiang; Zhaoshi Bao; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng; Wei Han
Journal:  Oncotarget       Date:  2016-04-12

2.  Fourth Ventricular Lesions in Metastatic Gliomas: A Rare Predilection?

Authors:  Mohammed Nazir Khan; Ariane Poulin; Marco Essig
Journal:  Brain Tumor Res Treat       Date:  2017-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.